Tumour debulking and reduction in predicted risk of tumour lysis syndrome with single-agent ibrutinib in patients with chronic lymphocytic leukaemia BRITISH JOURNAL OF HAEMATOLOGY Wierda, W. G., Byrd, J. C., O'Brien, S., Coutre, S., Barr, P. M., Furman, R. R., Kipps, T. J., Burger, J. A., Stevens, D. A., Sharman, J., Ghia, P., Flinn, I. W., Zhou, C., Ninomoto, J., James, D. F., Tam, C. S. 2019; 186 (1): 184–88

View details for DOI 10.1111/bjh.15791

View details for Web of Science ID 000472576700033